Kathryn Boger, Ph.D., said leaving academic medicine to co-found InStride Health was both terrifying and transformative. Boger reflected on advice she received early and said, “If you’re feeling scared, it’s a sign that you’re growing.” This wisdom continues to shape her path today.
Kathryn Boger, Ph.D., co-founder and chief clinical officer of InStride Health, is one of this year’s Managed Healthcare Executive Emerging Leaders in Healthcare.
In a recent video interview, she shared insights on the turning point that shaped her career, the one thing she would change about U.S. healthcare and a personal goal she’s striving for outside of work.
A pivotal moment in Boger’s career came when she decided to leave academic medicine—a field she believed she’d remain in long-term. After spending her postdoctoral and professional years at McLean Hospital, she took the leap to launch InStride Health.
“It was a risky one and really rewarding,” Boger said. “The pace and the rapid change is like nothing I had experienced before.”
She credits advice from her brother-in-law for helping her face her fears: “If you're feeling scared, it's a sign that you're growing.”
When asked what she would change about U.S. healthcare, Boger said she would ensure access to evidence-based mental health care for all families, regardless of income, location or background.
“At this point, there are just too many families who are going untreated or who aren’t getting the right treatments,” she said.
Reflecting on her previous role at McLean, Boger would get phone calls daily from families in need because their children were struggling and they weren't able to access the right care.
"So (we're) highly motivated to work on solving that problem," she added.
Her passion to expand access was a driving force behind co-founding InStride.
“That’s really the reason that we built InStride, was to provide access to care that is both evidence-based and insurance-backed,” she said.
Outside of her professional role, Boger is focused on a simple goal: being present.
A childhood memory of running laps with her cousin—earning sticks as somewhat of a prize—reminds her how much joy exists in the moment.
“I want to be able to appreciate the ride I’m on,” she said, “as opposed to just focus on the destination.”
Get the latest industry news, event updates, and more from Managed healthcare Executive.
A Conversation with Jeremiah Johnson, Executive Director of PrEP4All
July 25th 2025Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the importance of preexposure anaphylaxis and why he’s hesitant to jump on the Lenacapavir breakthrough bandwagon.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More